Skip to main content

Find Clinical Trials

Home
Conditions
Gliosarcoma

Clinical trial condition

Gliosarcoma

Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.

373 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Gliosarcoma trial results

Recruiting

Study of Pembrolizumab and M032 (NSC 733972)

NCT05084430

Conditions: Anaplastic Astrocytoma, Astrocytoma, Disease Attributes, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

NCT05465954

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Recruiting

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

NCT04541082

Conditions: Anaplastic Astrocytoma, Anaplastic Meningioma, Anaplastic Oligodendroglioma, +41 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Recruiting

Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

NCT06954636

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, Adult, +11 more
Locations: University Hospital Essen, Department of Neurology, Division of Clinical Neuro-Oncology Essen, Germany

Department of Neurosurgery Münster, Germany

View Trial Details

Not Yet Recruiting

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

NCT07422363

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: Not specified

View Trial Details

Completed

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma

NCT04396860

Conditions: Glioma, Gliosarcoma, MGMT-Unmethylated Glioblastoma, +7 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Kaiser Permanente-Anaheim Anaheim, California, United States

Sutter Auburn Faith Hospital Auburn, California, United States

View all 285 locations

View Trial Details

Completed

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

NCT04817254

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

NCT02709226

Conditions: Astrocytoma, Astrocytoma, Grade IV, Brain Diseases, +18 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

NCT03746080

Conditions: Astrocytoma, Glioblastoma, Glioblastoma With Primitive Neuronal Component, +11 more
Locations: Stanford Cancer Institute Palo Alto Palo Alto, California, United States

View Trial Details

Completed

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

NCT03174197

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details